[Comments on this legislation] [Post new comment] [Text and Analysis] [Add to Watch List]
[Previous] [Next]

• Introduced by Rep. Anne C. Perry (D) on December 21, 2007, the State of Maine through its Attorney General has received funds from Purdue Pharma, Inc., Purdue Pharma L.P. and the Purdue Frederick Company, Inc. pursuant to a consent judgment entered by the Kennebec County Superior Court in Docket No. CV-07-143. This judgment settled a civil action regarding Purdue's promotional and marketing practices for the prescription drug OxyContin. The consent judgment directed these funds to programs for prescription drug abuse prevention. The funds received by the Attorney General were transferred to the General Fund without designation for any purpose. This bill directs that those funds be directed to the Department of Health and Human Services, Office of Substance Abuse for the purpose of funding prescription drug abuse prevention or monitoring programs.
  • Referred to the Health and Human Services Committee on December 21, 2007.
• Received in the Senate on April 2, 2008.
• Failed in the Senate by voice vote on April 2, 2008, the senate/or house decided against further actions and the bill is dead.